(Q39036670)

8 September 2017

Clinical significance of CYLD downregulation in breast cancer (English)

1 reference

8 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24398777%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Satoshi Yamashita

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24398777%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Yukio Ando

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24398777%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Hirofumi Jono

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24398777%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Satoru Shinriki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24398777%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Takuya Nakamura

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24398777%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Jianying Guo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24398777%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Aiko Sueta

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24398777%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Mai Tomiguchi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24398777%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Saori Fujiwara

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24398777%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Mutsuko Yamamoto-Ibusuki

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24398777%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Kei-Ichi Murakami

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24398777%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Yutaka Yamamoto

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24398777%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Jian-Dong Li

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24398777%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Hirotaka Iwase

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24398777%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

language of work or name

English

0 references

publication date

8 January 2014

1 reference

Breast Cancer Research and Treatment

8 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24398777%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

143

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24398777%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24398777%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

447-457

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24398777%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10549-013-2824-3

13 June 2020

exact match

0 references

cites work

Identification of the familial cylindromatosis tumour-suppressor gene

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

Synergistic and feedback signaling mechanisms in the regulation of inflammation in respiratory infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

CYLD negatively regulates transforming growth factor-β-signalling via deubiquitinating Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

Loss of the tumor suppressor CYLD enhances Wnt/beta-catenin signaling through K63-linked ubiquitination of Dvl

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

Regulation of NF-κB by deubiquitinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

Reduced expression of CYLD in human colon and hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

Constitutive activation of nuclear factor-kappaB is preferentially involved in the proliferation of basal-like subtype breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

Activation of nuclear factor-kappaB (NFkappaB) identifies a high-risk subset of hormone-dependent breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

Nuclear factor-kappaB in cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

NF-kappa B inhibition markedly enhances sensitivity of resistant breast cancer tumor cells to tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

p53 stabilization is decreased upon NFkappaB activation: a role for NFkappaB in acquisition of resistance to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

Canonical and non-canonical NF-κB signaling promotes breast cancer tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

ErbB receptor tyrosine kinase/NF-κB signaling controls mammosphere formation in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

Breast cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

IKKalpha at the crossroads of inflammation and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

Control of mammary stem cell function by steroid hormone signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

Regulation of cancer cell migration and bone metastasis by RANKL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

Role of RANKL-induced osteoclast formation and MMP-dependent matrix degradation in bone destruction by breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

Denosumab in patients with cancer-a surgical strike against the osteoclast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

Expression of receptor activator of nuclear factor kappabeta ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathological

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2824-3

10.1007/S10549-013-2824-3

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24398777%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1 reference